Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Controlled, Double-blind, Multi-center Study to Assess Non-inferiority of Geistlich Fibro-Gide® in Comparison to Connective Tissue Graft for the Treatment of Recession Defects
Conditions
Interventions
Geistlich Fibro-Gide
Connective Tissue Graft (CTG
Locations
3
United States
Seven Lakes Periodontitis
Fenton, Michigan, United States
Perio Health Professionals
Houston, Texas, United States
Oral Health Specialists
Tacoma, Washington, United States
Start Date
September 1, 2018
Primary Completion Date
January 4, 2020
Completion Date
July 22, 2020
Last Updated
August 10, 2021
NCT07437417
NCT07200258
NCT07158541
NCT06409468
NCT06030947
NCT05688293
Lead Sponsor
Geistlich Pharma AG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions